Profile
Peter E.
Keipert is Vice President of Clinical and Regulatory Affairs for Sangart, Inc. Prior to joining Sangart in October, 2004 he was a Consultant of Alliance Pharmaceutical Corp., 1608557 Ontario, Inc. and Synzyme Technologies.
Dr. Keipert received a PhD with honors in Physiology from McGill University in 1985.
Former positions of Peter E. Keipert
| Companies | Position | End |
|---|---|---|
1608557 Ontario, Inc.
 1608557 Ontario, Inc. BiotechnologyHealth Technology 1608557 Ontario, Inc. develops and manufacturers biologics, particularly blood-related based therapeutics. The company was founded in 1985 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Alliance Pharmaceutical Corp.
 Alliance Pharmaceutical Corp. BiotechnologyHealth Technology Alliance Pharmaceutical Corp. is a research & development company, which focused on transformed innovative scientific discovered into novel therapeutic and diagnostic agents. It currently focused on developed its lead product, Oxygent, an intravascular oxygen carrier designed to augment oxygen deliveryed in surgical patients. The company was founded by Duane J. Roth in 1983 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Training of Peter E. Keipert
| McGill University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Alliance Pharmaceutical Corp.
Alliance Pharmaceutical Corp. BiotechnologyHealth Technology Alliance Pharmaceutical Corp. is a research & development company, which focused on transformed innovative scientific discovered into novel therapeutic and diagnostic agents. It currently focused on developed its lead product, Oxygent, an intravascular oxygen carrier designed to augment oxygen deliveryed in surgical patients. The company was founded by Duane J. Roth in 1983 and is headquartered in San Diego, CA. | Health Technology |
1608557 Ontario, Inc.
1608557 Ontario, Inc. BiotechnologyHealth Technology 1608557 Ontario, Inc. develops and manufacturers biologics, particularly blood-related based therapeutics. The company was founded in 1985 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Peter E. Keipert
